At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 428 enrolled
Drug / intervention
Varenicline plus Motivational Interviewing counseling +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Improving Varenicline Adherence and Outcomes in Homeless Smokers
In Brief
A Phase 3 clinical trial evaluating Varenicline plus Motivational Interviewing counseling and Varenicline without counseling for Tobacco Use Cessation. Completed, enrolled 428 participants across 1 site.
Detailed Summary
the purpose of the study is to see if varenicline in combination with motivational counseling helps homeless cigarette smokers quit smoking.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTobacco Use Cessation
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2007
First PostedNov 2008
Primary CompletionMar 2011
TodayJul 2026
First PostedNov 6, 2008
Enrollment StartSep 1, 2007
Primary CompletionMar 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 17.7 years ago
Interventions
Varenicline plus Motivational Interviewing counselingother
Motivational Interviewing; 8 weeks of counseling
Varenicline without counselingother
Brief advice, one time during initial session